Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lionel Perrier

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
BMC Health Services Research|September 22, 2021
Determinants of the need for respite according to the characteristics of informal carers of elderly people at home: results from the 2015 French national surveyWilfried Guets, Lionel Perrier
Bulletin Du Cancer|January 7, 2004
[The cost of cancer in France: macroeconomic and microeconomic approaches, evolution towards a prospective payment system]Lionel Perrier, Laurent Borella, Thierry Philip
Pharmacoeconomics|December 20, 2019
Cost-Utility Analyses of Interventions for Informal Carers: A Systematic and Critical ReviewWilfried Guets, Hareth Al-Janabi, Lionel Perrier
Journal of Medical Internet Research|May 20, 2022
How We Can Reap the Full Benefit of Teleconsultations: Economic Evaluation Combined With a Performance Evaluation Through a Discrete-Event SimulationMarius Huguet, Marianne Sarazin, Lionel Perrier, et al.
BMC Health Services Research|January 15, 2022
What underlies the observed hospital volume-outcome relationship?Marius Huguet, Xavier Joutard, Isabelle Ray-Coquard, et al.
Bulletin Du Cancer|September 25, 2021
How much does the hospital stay for infusion of anti-CD19 CAR-T cells cost to the French National Health Insurance?Marius Huguet, Véronique Raimond, Emmanuelle Kaltenbach, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 24, 2016
Cost evaluations of radiotherapy: What do we know? An ESTRO-HERO analysisNoémie Defourny, Peter Dunscombe, Lionel Perrier, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 22, 2019
Critical review and quality-assessment of cost analyses in radiotherapy: How reliable are the data?Noémie Defourny, Chris Monten, Cai Grau, et al.
International Archives of Occupational and Environmental Health|January 12, 2017
Varied exposure to carcinogenic, mutagenic, and reprotoxic (CMR) chemicals in occupational settings in FranceNathalie Havet, Alexis Penot, Magali Morelle, et al.
European Journal of Public Health|April 6, 2017
Trends in occupational disparities for exposure to carcinogenic, mutagenic and reprotoxic chemicals in France 2003-10Nathalie Havet, Alexis Penot, Magali Morelle, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
BMC Health Services Research|September 22, 2021
Determinants of the need for respite according to the characteristics of informal carers of elderly people at home: results from the 2015 French national surveyWilfried Guets, Lionel Perrier
Bulletin Du Cancer|January 7, 2004
[The cost of cancer in France: macroeconomic and microeconomic approaches, evolution towards a prospective payment system]Lionel Perrier, Laurent Borella, Thierry Philip
Pharmacoeconomics|December 20, 2019
Cost-Utility Analyses of Interventions for Informal Carers: A Systematic and Critical ReviewWilfried Guets, Hareth Al-Janabi, Lionel Perrier
Journal of Medical Internet Research|May 20, 2022
How We Can Reap the Full Benefit of Teleconsultations: Economic Evaluation Combined With a Performance Evaluation Through a Discrete-Event SimulationMarius Huguet, Marianne Sarazin, Lionel Perrier, et al.
BMC Health Services Research|January 15, 2022
What underlies the observed hospital volume-outcome relationship?Marius Huguet, Xavier Joutard, Isabelle Ray-Coquard, et al.
Bulletin Du Cancer|September 25, 2021
How much does the hospital stay for infusion of anti-CD19 CAR-T cells cost to the French National Health Insurance?Marius Huguet, Véronique Raimond, Emmanuelle Kaltenbach, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 24, 2016
Cost evaluations of radiotherapy: What do we know? An ESTRO-HERO analysisNoémie Defourny, Peter Dunscombe, Lionel Perrier, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 22, 2019
Critical review and quality-assessment of cost analyses in radiotherapy: How reliable are the data?Noémie Defourny, Chris Monten, Cai Grau, et al.
International Archives of Occupational and Environmental Health|January 12, 2017
Varied exposure to carcinogenic, mutagenic, and reprotoxic (CMR) chemicals in occupational settings in FranceNathalie Havet, Alexis Penot, Magali Morelle, et al.
European Journal of Public Health|April 6, 2017
Trends in occupational disparities for exposure to carcinogenic, mutagenic and reprotoxic chemicals in France 2003-10Nathalie Havet, Alexis Penot, Magali Morelle, et al.
Pageof 6